| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/20/2023 | -2.3% | Wedbush | → $32 | Reiterates | Neutral → Neutral |
| 11/02/2023 | 0.75% | Piper Sandler | $36 → $33 | Maintains | Neutral |
| 11/02/2023 | -20.62% | Barclays | $28 → $26 | Maintains | Underweight |
| 11/02/2023 | 6.85% | Stephens & Co. | $40 → $35 | Maintains | Overweight |
| 11/02/2023 | -2.3% | Wedbush | → $32 | Reiterates | Neutral → Neutral |
| 10/23/2023 | -14.52% | Barclays | $32 → $28 | Maintains | Underweight |
| 10/19/2023 | -2.3% | Deutsche Bank | → $32 | Initiates Coverage On | → Hold |
| 10/18/2023 | 0.75% | Citigroup | $39 → $33 | Maintains | Neutral |
| 10/11/2023 | -14.52% | Morgan Stanley | $31 → $28 | Maintains | Underweight |
| 10/05/2023 | 0.75% | B of A Securities | → $33 | Reinstates | → Neutral |
| 08/04/2023 | -5.36% | Morgan Stanley | $31 → $31 | Reiterates | Underweight → Underweight |
| 08/03/2023 | 17.54% | Wedbush | $36 → $38.5 | Maintains | Neutral |
| 08/03/2023 | 22.12% | Stephens & Co. | → $40 | Reiterates | Overweight → Overweight |
| 07/28/2023 | 9.91% | Wedbush | → $36 | Reiterates | Neutral → Neutral |
| 07/26/2023 | — | Kalinowski Research | Downgrades | Buy → Neutral | |
| 07/24/2023 | 12.96% | Citigroup | $36 → $37 | Maintains | Neutral |
| 07/18/2023 | 9.91% | Piper Sandler | → $36 | Initiates Coverage On | Neutral → Neutral |
| 07/17/2023 | -5.36% | Morgan Stanley | $31 → $31 | Reiterates | Underweight → Underweight |
| 06/26/2023 | 0.75% | Wells Fargo | → $33 | Initiates Coverage On | → Equal-Weight |
| 05/11/2023 | 9.91% | Wedbush | → $36 | Reiterates | Neutral → Neutral |
| 05/11/2023 | -2.3% | Barclays | $30 → $32 | Maintains | Underweight |
| 05/11/2023 | 22.12% | Stephens & Co. | → $40 | Reiterates | → Overweight |
| 04/24/2023 | 6.85% | Citigroup | $39 → $35 | Maintains | Neutral |
| 03/03/2023 | 16.01% | JP Morgan | $35 → $38 | Maintains | Neutral |
| 02/23/2023 | 28.22% | Credit Suisse | $37 → $42 | Maintains | Neutral |
| 02/23/2023 | 19.07% | Baird | $33 → $39 | Maintains | Neutral |
| 02/23/2023 | -8.41% | Barclays | $28 → $30 | Maintains | Underweight |
| 02/23/2023 | 22.12% | Stephens & Co. | $38 → $40 | Maintains | Overweight |
| 02/23/2023 | 34.33% | Wedbush | $40 → $44 | Maintains | Neutral |
| 02/22/2023 | 16.01% | Stephens & Co. | → $38 | Reiterates | → Overweight |
| 02/08/2023 | 22.12% | Wedbush | $33 → $40 | Maintains | Neutral |
| 01/25/2023 | -8.41% | UBS | → $30 | Downgrades | Neutral → Sell |
| 01/24/2023 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 01/18/2023 | -5.36% | Morgan Stanley | $26 → $31 | Maintains | Underweight |
| 01/17/2023 | 19.07% | Citigroup | → $39 | Downgrades | Buy → Neutral |
| 01/05/2023 | -14.52% | Barclays | $31 → $28 | Maintains | Underweight |
| 12/12/2022 | -11.46% | Goldman Sachs | $35 → $29 | Downgrades | Neutral → Sell |
| 12/02/2022 | 6.85% | Wedbush | $37 → $35 | Downgrades | Outperform → Neutral |
| 11/02/2022 | 9.91% | Deutsche Bank | $31 → $36 | Maintains | Hold |
| 11/02/2022 | -5.36% | Barclays | $28 → $31 | Maintains | Underweight |
| 11/02/2022 | 19.07% | Citigroup | $36 → $39 | Maintains | Buy |
| 11/02/2022 | 12.96% | Wedbush | $38 → $37 | Maintains | Outperform |
| 09/23/2022 | 16.01% | Stephens & Co. | → $38 | Initiates Coverage On | → Overweight |
| 07/28/2022 | -14.52% | Barclays | $32 → $28 | Maintains | Underweight |
| 07/28/2022 | 12.96% | Credit Suisse | $48 → $37 | Maintains | Neutral |
| 07/26/2022 | -8.41% | UBS | $42 → $30 | Maintains | Neutral |
| 07/19/2022 | 9.91% | Raymond James | $48 → $36 | Maintains | Outperform |
| 07/18/2022 | -20.62% | Morgan Stanley | $37 → $26 | Maintains | Underweight |
| 07/11/2022 | -8.41% | Piper Sandler | $38 → $30 | Maintains | Neutral |
| 07/05/2022 | 6.85% | Deutsche Bank | $43 → $35 | Maintains | Hold |
| 06/16/2022 | 31.28% | Citigroup | $52 → $43 | Maintains | Buy |
| 06/13/2022 | 16.01% | Piper Sandler | $44 → $38 | Maintains | Neutral |
| 06/09/2022 | -2.3% | Barclays | $39 → $32 | Maintains | Underweight |
| 04/28/2022 | 46.54% | Credit Suisse | $52 → $48 | Maintains | Neutral |
| 04/28/2022 | 49.6% | Wedbush | $52 → $49 | Maintains | Outperform |
| 04/14/2022 | 9.91% | Morgan Stanley | $39 → $36 | Maintains | Underweight |
| 04/12/2022 | 58.75% | Citigroup | → $52 | Initiates Coverage On | → Buy |
| 02/17/2022 | 19.07% | Morgan Stanley | $38 → $39 | Maintains | Underweight |
| 02/17/2022 | 58.75% | Wedbush | $49 → $52 | Maintains | Outperform |
| 02/17/2022 | 58.75% | Stephens & Co. | $47 → $52 | Maintains | Overweight |
| 02/11/2022 | 49.6% | Wedbush | $52 → $49 | Maintains | Outperform |
| 01/26/2022 | 46.54% | Raymond James | $52.5 → $48 | Maintains | Outperform |
| 01/14/2022 | 16.01% | Morgan Stanley | $43 → $38 | Maintains | Underweight |
| 01/05/2022 | 43.49% | Stephens & Co. | $53 → $47 | Upgrades | Equal-Weight → Overweight |
| 01/03/2022 | 34.33% | Piper Sandler | $65 → $44 | Downgrades | Overweight → Neutral |
| 12/15/2021 | 12.96% | Barclays | $40 → $37 | Maintains | Underweight |
| 11/08/2021 | 61.81% | Stephens & Co. | $50 → $53 | Maintains | Equal-Weight |
| 11/04/2021 | 58.75% | Credit Suisse | $62 → $52 | Maintains | Neutral |
| 11/04/2021 | 60.28% | Raymond James | $60 → $52.5 | Maintains | Outperform |
| 10/28/2021 | 52.65% | Wedbush | $55 → $50 | Maintains | Outperform |
| 10/25/2021 | 80.13% | Wells Fargo | $64 → $59 | Maintains | Overweight |
| 10/19/2021 | 52.65% | Stephens & Co. | $58 → $50 | Maintains | Equal-Weight |
| 09/24/2021 | 83.18% | Jefferies | $55 → $60 | Upgrades | Hold → Buy |
| 08/25/2021 | 67.91% | Wedbush | $70 → $55 | Maintains | Outperform |
| 07/12/2021 | 83.18% | Raymond James | → $60 | Upgrades | Market Perform → Outperform |
| 04/29/2021 | 77.07% | Credit Suisse | $47 → $58 | Maintains | Neutral |
| 04/29/2021 | 101.5% | Telsey Advisory Group | $62 → $66 | Maintains | Market Perform |
| 04/29/2021 | 37.38% | Morgan Stanley | $41 → $45 | Maintains | Underweight |
| 04/29/2021 | 83.18% | Stephens & Co. | $50 → $60 | Maintains | Equal-Weight |
| 04/29/2021 | 113.71% | Wedbush | $64 → $70 | Maintains | Outperform |
| 04/15/2021 | 89.28% | Telsey Advisory Group | $45 → $62 | Maintains | Market Perform |
| 03/26/2021 | 25.17% | Morgan Stanley | $36 → $41 | Maintains | Underweight |
| 03/11/2021 | 95.39% | Wedbush | $55 → $64 | Maintains | Outperform |
| 02/19/2021 | 43.49% | Goldman Sachs | $37 → $47 | Maintains | Neutral |
| 02/18/2021 | 9.91% | Morgan Stanley | $30 → $36 | Maintains | Underweight |
| 02/18/2021 | 28.22% | Stephens & Co. | $36 → $42 | Maintains | Equal-Weight |
| 02/09/2021 | 67.91% | Wedbush | $49 → $55 | Maintains | Outperform |
| 01/28/2021 | 43.49% | Deutsche Bank | → $47 | Downgrades | Buy → Hold |
| 01/25/2021 | 34.33% | JP Morgan | $38 → $44 | Upgrades | Underweight → Neutral |
| 01/19/2021 | 12.96% | Goldman Sachs | → $37 | Initiates Coverage On | → Neutral |
| 01/19/2021 | -8.41% | Morgan Stanley | $27 → $30 | Maintains | Underweight |
| 01/07/2021 | 9.91% | Stephens & Co. | $25 → $36 | Upgrades | Underweight → Equal-Weight |
| 11/13/2020 | — | Wedbush | Upgrades | Neutral → Outperform | |
| 11/09/2020 | 22.12% | Deutsche Bank | → $40 | Upgrades | Hold → Buy |
| 11/02/2020 | -2.3% | Credit Suisse | $26 → $32 | Maintains | Neutral |
| 11/02/2020 | -17.57% | Morgan Stanley | $26 → $27 | Maintains | Underweight |
| 10/30/2020 | -23.68% | Stephens & Co. | $18 → $25 | Maintains | Underweight |
| 10/19/2020 | -5.36% | Wedbush | $26 → $31 | Maintains | Neutral |
| 10/14/2020 | -20.62% | Morgan Stanley | $19 → $26 | Maintains | Underweight |
| 09/18/2020 | 16.01% | Piper Sandler | $30 → $38 | Maintains | Overweight |
| 07/30/2020 | -8.41% | Piper Sandler | $27 → $30 | Maintains | Overweight |
| 07/30/2020 | -20.62% | Wedbush | $24 → $26 | Maintains | Neutral |
| 07/30/2020 | -45.05% | Stephens & Co. | $15 → $18 | Maintains | Underweight |
| 07/14/2020 | -26.73% | Wedbush | $26 → $24 | Maintains | Neutral |
| 07/13/2020 | -54.21% | Stephens & Co. | $14 → $15 | Maintains | Underweight |
| 07/09/2020 | -26.73% | Credit Suisse | → $24 | Initiates Coverage On | → Neutral |
| 06/24/2020 | -29.78% | JP Morgan | → $23 | Downgrades | Neutral → Underweight |
| 06/05/2020 | -5.36% | Wells Fargo | $26 → $31 | Maintains | Overweight |
| 06/04/2020 | -17.57% | Piper Sandler | $23 → $27 | Maintains | Overweight |
| 05/13/2020 | -57.26% | Stephens & Co. | → $14 | Reinstates | → Underweight |
| 05/12/2020 | -41.99% | JP Morgan | $29 → $19 | Maintains | Neutral |
| 05/06/2020 | -32.83% | CFRA | $20 → $22 | Maintains | Hold |
| 05/06/2020 | -38.94% | UBS | $43 → $20 | Maintains | Neutral |
| 05/06/2020 | -51.15% | Morgan Stanley | $13 → $16 | Maintains | Underweight |
| 05/06/2020 | -32.83% | Wedbush | $20 → $22 | Maintains | Neutral |
| 04/23/2020 | -20.62% | Wells Fargo | $50 → $26 | Maintains | Overweight |
| 04/22/2020 | -38.94% | Jefferies | $18 → $20 | Maintains | Hold |
| 04/21/2020 | -38.94% | Baird | $19 → $20 | Maintains | Neutral |
| 04/17/2020 | -38.94% | CFRA | $42 → $20 | Maintains | Hold |
| 04/14/2020 | -20.62% | Deutsche Bank | $41 → $26 | Maintains | Hold |
| 04/08/2020 | -38.94% | Wedbush | $43 → $20 | Maintains | Neutral |
| 04/02/2020 | -20.62% | Piper Sandler | $55 → $26 | Maintains | Overweight |
| 03/31/2020 | — | Gordon Haskett | Upgrades | Hold → Buy | |
| 03/27/2020 | -48.1% | Baird | $20 → $17 | Maintains | Neutral |
| 03/24/2020 | -45.05% | Baird | $30 → $18 | Maintains | Neutral |
| 03/02/2020 | 43.49% | Guggenheim | → $47 | Upgrades | Neutral → Buy |
| 02/20/2020 | 9.91% | Barclays | $39 → $36 | Maintains | Underweight |
| 02/20/2020 | 28.22% | CFRA | $45 → $42 | Maintains | Hold |
| 02/20/2020 | 25.17% | Deutsche Bank | $43 → $41 | Maintains | Hold |
| 02/20/2020 | 31.28% | B of A Securities | $45 → $43 | Reiterates | → Neutral |
| 02/20/2020 | 31.28% | Wedbush | $42 → $43 | Maintains | Neutral |
| 02/18/2020 | 31.28% | UBS | $47 → $43 | Maintains | Neutral |
| 01/17/2020 | 16.01% | Morgan Stanley | $44 → $38 | Downgrades | Equal-Weight → Underweight |
| 12/19/2019 | 34.33% | Morgan Stanley | $45 → $44 | Maintains | Equal-Weight |
| 12/12/2019 | 25.17% | Goldman Sachs | → $41 | Initiates Coverage On | → Neutral |
| 10/30/2019 | 37.38% | Morgan Stanley | $43 → $45 | Maintains | Equal-Weight |
| 10/18/2019 | 31.28% | Morgan Stanley | $47 → $43 | Maintains | Equal-Weight |
| 10/18/2019 | 12.96% | Barclays | $40 → $37 | Maintains | Underweight |
| 10/17/2019 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 09/06/2019 | — | Wells Fargo | Upgrades | Market Perform → Outperform | |
| 08/01/2019 | 31.28% | Wedbush | $45 → $43 | Maintains | Neutral |
| 08/01/2019 | 40.44% | Wells Fargo | $47 → $46 | Maintains | Market Perform |
| 07/15/2019 | 61.81% | Raymond James | $56 → $53 | Maintains | Outperform |
| 06/28/2019 | 37.38% | JP Morgan | $52 → $45 | Maintains | Neutral |
| 06/28/2019 | 40.44% | Deutsche Bank | → $46 | Initiates Coverage On | → Hold |
| 05/02/2019 | 28.22% | Barclays | $40 → $42 | Maintains | Underweight |
| 05/02/2019 | 52.65% | Wedbush | $48 → $50 | Maintains | Neutral |
| 04/26/2019 | — | UBS | Initiates Coverage On | → Neutral | |
| 01/08/2019 | — | Raymond James | Upgrades | Market Perform → Outperform | |
| 11/29/2018 | 34.33% | Barclays | $47 → $44 | Maintains | Underweight |
What is the target price for Cheesecake Factory (CAKE)?
The latest price target for Cheesecake Factory (NASDAQ: CAKE) was reported by Wedbush on November 20, 2023. The analyst firm set a price target for $32.00 expecting CAKE to fall to within 12 months (a possible -2.30% downside). 38 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cheesecake Factory (CAKE)?
The latest analyst rating for Cheesecake Factory (NASDAQ: CAKE) was provided by Wedbush, and Cheesecake Factory reiterated their neutral rating.
When is the next analyst rating going to be posted or updated for Cheesecake Factory (CAKE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cheesecake Factory, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cheesecake Factory was filed on November 20, 2023 so you should expect the next rating to be made available sometime around November 20, 2024.
Is the Analyst Rating Cheesecake Factory (CAKE) correct?
While ratings are subjective and will change, the latest Cheesecake Factory (CAKE) rating was a reiterated with a price target of $0.00 to $32.00. The current price Cheesecake Factory (CAKE) is trading at is $32.76, which is out of the analyst's predicted range.